-DOCSTART- -X- O
A -X- _ O
focused -X- _ O
nucleoside -X- _ O
library -X- _ O
was -X- _ O
constructed -X- _ O
around -X- _ O
a -X- _ O
3â€²-C-ethynyl-d-ribofuranose -X- _ B-Patient
sugar -X- _ I-Patient
scaffold -X- _ I-Patient
, -X- _ O
which -X- _ O
was -X- _ O
coupled -X- _ O
to -X- _ O
variously -X- _ O
modified -X- _ O
purine -X- _ O
nucleobases. -X- _ O
The -X- _ O
resulting -X- _ O
nucleosides -X- _ O
were -X- _ O
probed -X- _ O
for -X- _ O
their -X- _ O
ability -X- _ O
to -X- _ O
inhibit -X- _ O
tumor -X- _ O
cell -X- _ O
proliferation -X- _ O
, -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
for -X- _ O
their -X- _ O
activity -X- _ O
against -X- _ O
a -X- _ O
panel -X- _ O
of -X- _ O
relevant -X- _ O
human -X- _ O
viruses. -X- _ O
While -X- _ O
C6-aryl -X- _ B-Intervention
substituted -X- _ I-Intervention
purine -X- _ I-Intervention
nucleosides -X- _ I-Intervention
were -X- _ O
found -X- _ B-Outcome
to -X- _ I-Outcome
be -X- _ I-Outcome
weakly -X- _ I-Outcome
active -X- _ I-Outcome
, -X- _ I-Outcome
several -X- _ I-Outcome
C7-substituted -X- _ B-Intervention
7-deazapurine -X- _ I-Intervention
nucleosides -X- _ I-Intervention
elicited -X- _ B-Outcome
potent -X- _ I-Outcome
antiproliferative -X- _ I-Outcome
activity. -X- _ I-Outcome
Their -X- _ O
activity -X- _ O
spectrum -X- _ O
was -X- _ O
evaluated -X- _ O
in -X- _ O
the -X- _ O
NCI-60 -X- _ O
tumor -X- _ O
cell -X- _ O
line -X- _ O
panel -X- _ O
indicating -X- _ O
activity -X- _ O
against -X- _ O
several -X- _ O
solid -X- _ O
tumor -X- _ O
derived -X- _ O
cell -X- _ O
lines. -X- _ O
Analog -X- _ B-Intervention
32 -X- _ I-Intervention
, -X- _ I-Intervention
equipped -X- _ I-Intervention
with -X- _ I-Intervention
a -X- _ I-Intervention
7-deaza -X- _ I-Intervention
7-chloro-6-amino-purin-9-yl -X- _ I-Intervention
base -X- _ I-Intervention
was -X- _ O
evaluated -X- _ O
in -X- _ O
a -X- _ O
metastatic -X- _ O
breast -X- _ O
tumor -X- _ O
( -X- _ O
MDA-MB-231-LM2 -X- _ O
) -X- _ O
xenograft -X- _ O
model. -X- _ O
It -X- _ O
inhibited -X- _ B-Outcome
both -X- _ I-Outcome
tumor -X- _ I-Outcome
growth -X- _ I-Outcome
and -X- _ I-Outcome
reduced -X- _ I-Outcome
the -X- _ I-Outcome
formation -X- _ I-Outcome
of -X- _ I-Outcome
lung -X- _ I-Outcome
metastases -X- _ I-Outcome
as -X- _ I-Outcome
revealed -X- _ I-Outcome
by -X- _ I-Outcome
BLI -X- _ I-Outcome
analysis. -X- _ I-Outcome
The -X- _ O
dideazanucleoside -X- _ B-Intervention
analog -X- _ I-Intervention
66 -X- _ I-Intervention
showed -X- _ O
interesting -X- _ B-Outcome
activity -X- _ I-Outcome
against -X- _ I-Outcome
hCMV. -X- _ I-Outcome
These -X- _ O
results -X- _ O
highlight -X- _ O
the -X- _ O
potential -X- _ O
advantages -X- _ O
of -X- _ O
recombining -X- _ O
known -X- _ O
sugar -X- _ O
and -X- _ O
nucleobase -X- _ O
motifs -X- _ O
as -X- _ O
a -X- _ O
library -X- _ O
design -X- _ O
strategy -X- _ O
to -X- _ O
discover -X- _ O
novel -X- _ O
antiviral -X- _ O
or -X- _ O
antitumor -X- _ O
agents -X- _ O
. -X- _ O

